| Title |
Cellular and Molecular Pathways of COVID-19 and Potential Points of Therapeutic Intervention
|
|---|---|
| Published in |
Frontiers in Pharmacology, July 2020
|
| DOI | 10.3389/fphar.2020.01169 |
| Pubmed ID | |
| Authors |
John P Hussman |
X Demographics
The data shown below were collected from the profiles of 99 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 17 | 17% |
| Venezuela, Bolivarian Republic of | 6 | 6% |
| Japan | 5 | 5% |
| United Kingdom | 4 | 4% |
| Mexico | 3 | 3% |
| Spain | 2 | 2% |
| Ghana | 1 | 1% |
| Australia | 1 | 1% |
| Papua New Guinea | 1 | 1% |
| Other | 8 | 8% |
| Unknown | 51 | 52% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 90 | 91% |
| Scientists | 7 | 7% |
| Practitioners (doctors, other healthcare professionals) | 2 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 368 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 368 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 44 | 12% |
| Researcher | 39 | 11% |
| Student > Master | 38 | 10% |
| Student > Ph. D. Student | 24 | 7% |
| Student > Doctoral Student | 16 | 4% |
| Other | 56 | 15% |
| Unknown | 151 | 41% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 77 | 21% |
| Biochemistry, Genetics and Molecular Biology | 43 | 12% |
| Immunology and Microbiology | 17 | 5% |
| Agricultural and Biological Sciences | 15 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 15 | 4% |
| Other | 36 | 10% |
| Unknown | 165 | 45% |
Attention Score in Context
This research output has an Altmetric Attention Score of 83. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 November 2022.
All research outputs
#529,708
of 25,877,363 outputs
Outputs from Frontiers in Pharmacology
#199
of 20,035 outputs
Outputs of similar age
#15,948
of 429,625 outputs
Outputs of similar age from Frontiers in Pharmacology
#10
of 438 outputs
Altmetric has tracked 25,877,363 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 20,035 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 429,625 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 438 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.